| # | Title | Journal | Year | Citations |
|---|
| 1 | Early colon cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up | Annals of Oncology | 2013 | 874 |
| 2 | Neurodevelopmental outcome at 2 years of age after general anaesthesia and awake-regional anaesthesia in infancy (GAS): an international multicentre, randomised controlled trial | Lancet, The | 2016 | 865 |
| 3 | Localised colon cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up | Annals of Oncology | 2020 | 591 |
| 4 | Optical coherence tomography compared with intravascular ultrasound and with angiography to guide coronary stent implantation (ILUMIEN III: OPTIMIZE PCI): a randomised controlled trial | Lancet, The | 2016 | 473 |
| 5 | Tailoring Adjuvant Endocrine Therapy for Premenopausal Breast Cancer | New England Journal of Medicine | 2018 | 448 |
| 6 | Clinical use of intracoronary imaging. Part 1: guidance and optimization of coronary interventions. An expert consensus document of the European Association of Percutaneous Cardiovascular Interventions | European Heart Journal | 2018 | 431 |
| 7 | Addressing the challenges of pancreatic cancer: Future directions for improving outcomes | Pancreatology | 2015 | 404 |
| 8 | Long-term findings from COMFORT-II, a phase 3 study of ruxolitinib vs best available therapy for myelofibrosis | Leukemia | 2016 | 393 |
| 9 | PAX5-driven subtypes of B-progenitor acute lymphoblastic leukemia | Nature Genetics | 2019 | 384 |
| 10 | Axillary dissection versus no axillary dissection in patients with breast cancer and sentinel-node micrometastases (IBCSG 23-01): 10-year follow-up of a randomised, controlled phase 3 trial | Lancet Oncology, The | 2018 | 342 |
| 11 | Revised response criteria for myelofibrosis: International Working Group-Myeloproliferative Neoplasms Research and Treatment (IWG-MRT) and European LeukemiaNet (ELN) consensus report | Blood | 2013 | 286 |
| 12 | Developing Therapies for Heart Failure With Preserved Ejection Fraction | JACC: Heart Failure | 2014 | 267 |
| 13 | Colchicine for Prevention of Postpericardiotomy Syndrome and Postoperative Atrial Fibrillation | JAMA - Journal of the American Medical Association | 2014 | 258 |
| 14 | Indication and management of allogeneic stem cell transplantation in primary myelofibrosis: a consensus process by an EBMT/ELN international working group | Leukemia | 2015 | 242 |
| 15 | Effect of Anakinra on Recurrent Pericarditis Among Patients With Colchicine Resistance and Corticosteroid Dependence | JAMA - Journal of the American Medical Association | 2016 | 242 |
| 16 | Management and Long-Term Prognosis of Spontaneous Coronary Artery Dissection | American Journal of Cardiology | 2015 | 230 |
| 17 | Assessment of a HER2 scoring system for colorectal cancer: results from a validation study | Modern Pathology | 2015 | 226 |
| 18 | Revised response criteria for polycythemia vera and essential thrombocythemia: an ELN and IWG-MRT consensus project | Blood | 2013 | 219 |
| 19 | Contrast-induced acute kidney injury after primary percutaneous coronary intervention: results from the HORIZONS-AMI substudy | European Heart Journal | 2014 | 210 |
| 20 | Baroreflex Activation Therapy for the Treatment of Heart Failure With a Reduced Ejection Fraction | JACC: Heart Failure | 2015 | 204 |
| 21 | Autologous hematopoietic stem cell transplantation in multiple sclerosis | Neurology | 2015 | 201 |
| 22 | Microthrombi as a Major Cause of Cardiac Injury in COVID-19 | Circulation | 2021 | 196 |
| 23 | Clinical use of intracoronary imaging. Part 2: acute coronary syndromes, ambiguous coronary angiography findings, and guiding interventional decision-making: an expert consensus document of the European Association of Percutaneous Cardiovascular Interventions | European Heart Journal | 2019 | 189 |
| 24 | Pathological Evidence for SARS-CoV-2 as a Cause of Myocarditis | Journal of the American College of Cardiology | 2021 | 177 |
| 25 | Tumour-derived PGD2 and NKp30-B7H6 engagement drives an immunosuppressive ILC2-MDSC axis | Nature Communications | 2017 | 175 |
| 26 | State of the art: Reproduction and pregnancy in rheumatic diseases | Autoimmunity Reviews | 2015 | 169 |
| 27 | Liver transplantation in hepatocellular carcinoma after tumour downstaging (XXL): a randomised, controlled, phase 2b/3 trial | Lancet Oncology, The | 2020 | 166 |
| 28 | Development and evaluation of a clinical staging system for amyotrophic lateral sclerosis | Journal of Neurology, Neurosurgery and Psychiatry | 2015 | 160 |
| 29 | Flash survey on severe acute respiratory syndrome coronavirus-2 infections in paediatric patients on anticancer treatment | European Journal of Cancer | 2020 | 155 |
| 30 | Triage strategy for urgent management of cardiac tamponade: a position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases | European Heart Journal | 2014 | 154 |
| 31 | Clinical Portrait of the SARS-CoV-2 Epidemic in European Patients with Cancer | Cancer Discovery | 2020 | 151 |
| 32 | Transaortic Chordal Cutting | Journal of the American College of Cardiology | 2015 | 141 |
| 33 | Subclinical Carotid Atherosclerosis and Early Vascular Aging From Long-Term Low-Dose Ionizing Radiation Exposure | JACC: Cardiovascular Interventions | 2015 | 135 |
| 34 | Myeloproliferative neoplasms and inflammation: whether to target the malignant clone or the inflammatory process or both | Leukemia | 2016 | 130 |
| 35 | Pegylated interferon alfa-2a for polycythemia vera or essential thrombocythemia resistant or intolerant to hydroxyurea | Blood | 2019 | 123 |
| 36 | Nivolumab Combined With Brentuximab Vedotin for Relapsed/Refractory Primary Mediastinal Large B-Cell Lymphoma: Efficacy and Safety From the Phase II CheckMate 436 Study | Journal of Clinical Oncology | 2019 | 120 |
| 37 | Monogenic diseases that can be cured by liver transplantation | Journal of Hepatology | 2013 | 111 |
| 38 | A phase II study of Givinostat in combination with hydroxycarbamide in patients with polycythaemia vera unresponsive to hydroxycarbamide monotherapy | British Journal of Haematology | 2013 | 109 |
| 39 | Optical coherence tomography in coronary atherosclerosis assessment and intervention | Nature Reviews Cardiology | 2022 | 106 |
| 40 | Lessons for the clinic from rituximab pharmacokinetics and pharmacodynamics | MAbs | 2013 | 105 |
| 41 | Philadelphia chromosome-negative chronic myeloproliferative neoplasms: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up | Annals of Oncology | 2015 | 105 |
| 42 | Adjuvant Tamoxifen Plus Ovarian Function Suppression Versus Tamoxifen Alone in Premenopausal Women With Early Breast Cancer: Patient-Reported Outcomes in the Suppression of Ovarian Function Trial | Journal of Clinical Oncology | 2016 | 100 |
| 43 | In-hospital and 1-year outcomes of acute heart failure patients according to presentation (de novo vs. worsening) and ejection fraction. Results from IN-HF Outcome Registry | International Journal of Cardiology | 2014 | 98 |
| 44 | Anakinra for corticosteroid-dependent and colchicine-resistant pericarditis: The IRAP (International Registry of Anakinra for Pericarditis) study | European Journal of Preventive Cardiology | 2020 | 98 |
| 45 | Absolute Improvements in Freedom From Distant Recurrence to Tailor Adjuvant Endocrine Therapies for Premenopausal Women: Results From TEXT and SOFT | Journal of Clinical Oncology | 2020 | 93 |
| 46 | Clinical use of intracoronary imaging. Part 1: guidance and optimization of coronary interventions. An expert consensus document of the European Association of Percutaneous Cardiovascular Interventions | EuroIntervention | 2018 | 92 |
| 47 | Surgery of the lateral skull base: a 50-year endeavour | Acta Otorhinolaryngologica Italica | 2019 | 91 |
| 48 | Baroreflex activation therapy for the treatment of heart failure with a reduced ejection fraction: safety and efficacy in patients with and without cardiac resynchronization therapy | European Journal of Heart Failure | 2015 | 85 |
| 49 | Randomized trial on adjuvant treatment with FOLFIRI followed by docetaxel and cisplatin versus 5-fluorouracil and folinic acid for radically resected gastric cancer | Annals of Oncology | 2014 | 84 |
| 50 | Pomalidomide, cyclophosphamide, and prednisone for relapsed/refractory multiple myeloma: a multicenter phase 1/2 open-label study | Blood | 2013 | 80 |
